Hypertension in women of reproductive age in the United States: NHANES 1999-2008

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Bateman, Brian T ^a   Shaw, Kate M ^b   Kuklina, Elena V ^b   Callaghan, William M ^b   Seely, Ellen W ^c   Hernández Díaz, Sonia ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CAUCASIAN; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; DIABETES MELLITUS; DRUG UTILIZATION; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NEGRO; OBESITY; PREVALENCE; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; UNITED STATES; WOMEN'S HEALTH; CROSS-SECTIONAL STUDY; INFORMATION PROCESSING; MATERNAL AGE; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; REPRODUCTION;

ADULT; AGE FACTORS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HUMANS; HYPERTENSION; MATERNAL AGE; NUTRITIONAL STATUS; REPRODUCTION; UNITED STATES; YOUNG ADULT;

EID: 84860428492     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036171     Document Type: Article

References (39)

1. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, et al. (2004) The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44: 398-404.
2. Centers for Disease Control and Prevention (2011) Vital signs: prevalence, treatment, and control of hypertension - United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep 60: 103-108.
3. Hsiao CJ, Cherry DK, Beatty PC, Rechtsteiner EA, (2010) National Ambulatory Medical Care Survey: 2007 summary. Natl Health Stat Report pp. 1-32.
4. Yoder SR, Thornburg LL, Bisognano JD, (2009) Hypertension in pregnancy and women of childbearing age. Am J Med 122: 890-895.
5. Daviglus ML, Stamler J, Pirzada A, Yan LL, Garside DB, et al. (2004) Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA 292: 1588-1592.
6. Ford ES, Capewell S, (2007) Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 50: 2128-2132.
7. American College of Obstetricians and Gynecologists (2001) ACOG Practice Bulletin. Chronic hypertension in pregnancy. ACOG Committee on Practice Bulletins. Obstet Gynecol 98: (suppl 177-185).
8. Sibai BM, (2002) Chronic hypertension in pregnancy. Obstet Gynecol 100: 369-377.
9. Sibai BM, Abdella TN, Anderson GD, (1983) Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 61: 571-576.
10. Sibai BM, Lindheimer M, Hauth J, Caritis S, VanDorsten P, et al. (1998) Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 339: 667-671.
11. Rey E, Couturier A, (1994) The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 171: 410-416.
12. Kuklina EV, Ayala C, Callaghan WM, (2009) Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 113: 1299-1306.
13. Bateman BT, Schumacher HC, Bushnell CD, Pile-Spellman J, Simpson LL, et al. (2006) Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology 67: 424-429.
14. Gilbert WM, Young AL, Danielsen B, (2007) Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med 52: 1046-1051.
15. Jain L, (1997) Effect of pregnancy-induced and chronic hypertension on pregnancy outcome. J Perinatol 17: 425-427.
16. Ananth CV, Savitz DA, Bowes WA Jr, (1995) Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991. Acta Obstet Gynecol Scand 74: 788-793.
17. Egan BM, Zhao Y, Axon RN, (2010) US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 303: 2043-2050.
18. Centers for Disease Control and Prevention (2007) Prevalence of chronic kidney disease and associated risk factors - United States, 1999-2004. MMWR Morb Mortal Wkly Rep 56: 161-165.
19. Flegal KM, Carroll MD, Ogden CL, Curtin LR, (2010) Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303: 235-241.
20. Kim SY, Dietz PM, England L, Morrow B, Callaghan WM, (2007) Trends in pre-pregnancy obesity in nine states, 1993-2003. Obesity (Silver Spring) 15: 986-993.
21. Hertz RP, Unger AN, Cornell JA, Saunders E, (2005) Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med 165: 2098-2104.
22. Ashaye MO, Giles WH, (2003) Hypertension in Blacks: a literature review. Ethn Dis 13: 456-462.
23. Frieden TR, (2011) Forward: CDC Health Disparities and Inequalities Report- United States, 2011. MMWR Surveill Summ 60 Suppl pp. 1-2.
24. Samadi AR, Mayberry RM, Zaidi AA, Pleasant JC, McGhee N Jr, et al. (1996) Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol 87: 557-563.
25. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Mathews TJ, et al. (2010) Births: final data for 2007. Natl Vital Stat Rep 58: 1-85.
26. Kallen BA, Otterblad Olausson P, (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17: 255-261.
27. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, et al. (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354: 2443-2451.
28. Lennestal R, Otterblad Olausson P, Kallen B, (2009) Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 65: 615-625.
29. Caton AR, Bell EM, Druschel CM, Werler MM, Lin AE, et al. (2009) Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension 54: 63-70.
30. Nakhai-Pour HR, Rey E, Berard A, (2010) Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B Dev Reprod Toxicol 89: 147-154.
31. Davis RL, Eastman D, McPhillips H, Raebel MA, Andrade SE, et al. (2011) Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf 20: 138-145.
32. Li DK, Yang C, Andrade S, Tavares V, Ferber JR, (2011) Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 343: d5931.
33. Podymow T, August P, (2008) Update on the use of antihypertensive drugs in pregnancy. Hypertension 51: 960-969.
34. Finer LB, Henshaw SK, (2006) Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 38: 90-96.
35. Beilin LJ, Puddey IB, (2006) Alcohol and hypertension: an update. Hypertension 47: 1035-1038.
36. Lim KG, Isles CG, Hodsman GP, Lever AF, Robertson JW, (1987) Malignant hypertension in women of childbearing age and its relation to the contraceptive pill. Br Med J (Clin Res Ed) 294: 1057-1059.
37. Chasan-Taber L, Willett WC, Manson JE, Spiegelman D, Hunter DJ, et al. (1996) Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 94: 483-489.
38. Woods JW, (1988) Oral contraceptives and hypertension. Hypertension 11: II11-15.
39. Halperin RO, Gaziano JM, Sesso HD, (2008) Smoking and the risk of incident hypertension in middle-aged and older men. Am J Hypertens 21: 148-152.